• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Compatibility of aztreonam in four commercial peritoneal dialysis fluids.氨曲南在四种商业腹膜透析液中的相容性。
Sci Rep. 2020 Feb 4;10(1):1788. doi: 10.1038/s41598-020-58391-y.
2
Compatibility of fosfomycin with different commercial peritoneal dialysis solutions.磷霉素与不同商业腹膜透析液的相容性。
Eur J Clin Microbiol Infect Dis. 2017 Nov;36(11):2237-2242. doi: 10.1007/s10096-017-3051-3. Epub 2017 Jul 6.
3
Compatibility of Meropenem with Different Commercial Peritoneal Dialysis Solutions.美罗培南与不同商业腹膜透析液的相容性
Perit Dial Int. 2017;37(1):51-55. doi: 10.3747/pdi.2016.00018. Epub 2016 Sep 7.
4
Compatibility of ciprofloxacin with commercial peritoneal dialysis solutions.环丙沙星与商业腹膜透析液的相容性。
Sci Rep. 2019 Apr 24;9(1):6512. doi: 10.1038/s41598-019-42854-y.
5
Influence of different peritoneal dialysis fluids on the in vitro activity of fosfomycin against Escherichia coli, Staphylococcus aureus, Staphylococcus epidermidis, and Pseudomonas aeruginosa.不同腹膜透析液对磷霉素体外抗大肠埃希菌、金黄色葡萄球菌、表皮葡萄球菌和铜绿假单胞菌活性的影响。
Eur J Clin Microbiol Infect Dis. 2018 Jun;37(6):1091-1098. doi: 10.1007/s10096-018-3221-y. Epub 2018 Mar 15.
6
Stability and Compatibility of Antibiotics in Peritoneal Dialysis Solutions Applied to Automated Peritoneal Dialysis in The Pediatric Population.应用于儿科人群自动腹膜透析的腹膜透析液中抗生素的稳定性和相容性
Perit Dial Int. 2016;36(6):676-679. doi: 10.3747/pdi.2015.00018. Epub 2016 May 4.
7
Compatibility of linezolid with commercial peritoneal dialysis solutions.利奈唑胺与市售腹膜透析液的相容性。
Am J Health Syst Pharm. 2018 Oct 1;75(19):1467-1477. doi: 10.2146/ajhp170318.
8
Influence of Different Peritoneal Dialysis Fluids on the In Vitro Activity of Cefepime, Ciprofloxacin, Ertapenem, Meropenem and Tobramycin Against Escherichia Coli.不同腹膜透析液对头孢吡肟、环丙沙星、厄他培南、美罗培南和妥布霉素体外抗大肠杆菌活性的影响
Perit Dial Int. 2016;36(6):662-668. doi: 10.3747/pdi.2015.00161. Epub 2016 Sep 28.
9
Pyridine levels in ceftazidime - peritoneal dialysis admixtures stored at body temperature.头孢他啶-腹膜透析混合液在体温下储存时的吡啶水平。
Perit Dial Int. 2020 Mar;40(2):171-178. doi: 10.1177/0896860819887636. Epub 2020 Jan 17.
10
The influence of different peritoneal dialysis fluids on the in vitro activity of ampicillin, daptomycin, and linezolid against Enterococcus faecalis.不同腹膜透析液对氨苄西林、达托霉素和利奈唑胺体外抗粪肠球菌活性的影响。
Eur J Clin Microbiol Infect Dis. 2015 Nov;34(11):2257-63. doi: 10.1007/s10096-015-2477-8. Epub 2015 Sep 4.

引用本文的文献

1
Culture-directed antibiotics in peritoneal dialysis solutions: a systematic review focused on stability and compatibility.以文化为导向的腹膜透析液中的抗生素:一项关注稳定性和相容性的系统评价。
J Nephrol. 2023 Sep;36(7):1841-1859. doi: 10.1007/s40620-023-01716-7. Epub 2023 Aug 7.

本文引用的文献

1
Compatibility of ciprofloxacin with commercial peritoneal dialysis solutions.环丙沙星与商业腹膜透析液的相容性。
Sci Rep. 2019 Apr 24;9(1):6512. doi: 10.1038/s41598-019-42854-y.
2
Biocompatible dialysis fluids for peritoneal dialysis.用于腹膜透析的生物相容性透析液。
Cochrane Database Syst Rev. 2018 Oct 26;10(10):CD007554. doi: 10.1002/14651858.CD007554.pub3.
3
Compatibility of linezolid with commercial peritoneal dialysis solutions.利奈唑胺与市售腹膜透析液的相容性。
Am J Health Syst Pharm. 2018 Oct 1;75(19):1467-1477. doi: 10.2146/ajhp170318.
4
Influence of different peritoneal dialysis fluids on the in vitro activity of fosfomycin against Escherichia coli, Staphylococcus aureus, Staphylococcus epidermidis, and Pseudomonas aeruginosa.不同腹膜透析液对磷霉素体外抗大肠埃希菌、金黄色葡萄球菌、表皮葡萄球菌和铜绿假单胞菌活性的影响。
Eur J Clin Microbiol Infect Dis. 2018 Jun;37(6):1091-1098. doi: 10.1007/s10096-018-3221-y. Epub 2018 Mar 15.
5
Risk factors and outcomes for multidrug-resistant Gram-negative bacilli bacteremia.耐多药革兰氏阴性杆菌血症的危险因素及转归
Ther Adv Infect Dis. 2018 Jan;5(1):11-18. doi: 10.1177/2049936117727497. Epub 2017 Sep 12.
6
Compatibility of fosfomycin with different commercial peritoneal dialysis solutions.磷霉素与不同商业腹膜透析液的相容性。
Eur J Clin Microbiol Infect Dis. 2017 Nov;36(11):2237-2242. doi: 10.1007/s10096-017-3051-3. Epub 2017 Jul 6.
7
Microbiological Trends and Antimicrobial Resistance in Peritoneal Dialysis-Related Peritonitis, 2005 to 2014.2005年至2014年腹膜透析相关性腹膜炎的微生物学趋势及抗菌药物耐药性
Perit Dial Int. 2017 Mar-Apr;37(2):170-176. doi: 10.3747/pdi.2016.00136. Epub 2016 Oct 13.
8
Compatibility of Meropenem with Different Commercial Peritoneal Dialysis Solutions.美罗培南与不同商业腹膜透析液的相容性
Perit Dial Int. 2017;37(1):51-55. doi: 10.3747/pdi.2016.00018. Epub 2016 Sep 7.
9
ISPD Peritonitis Recommendations: 2016 Update on Prevention and Treatment.国际腹膜透析学会腹膜炎推荐意见:2016年预防与治疗更新版
Perit Dial Int. 2016 Sep 10;36(5):481-508. doi: 10.3747/pdi.2016.00078. Epub 2016 Jun 9.
10
Stability of anidulafungin in two standard peritoneal dialysis fluids.阿尼芬净在两种标准腹膜透析液中的稳定性
Perit Dial Int. 2014 Nov-Dec;34(7):798-802. doi: 10.3747/pdi.2012.00326.

氨曲南在四种商业腹膜透析液中的相容性。

Compatibility of aztreonam in four commercial peritoneal dialysis fluids.

机构信息

Department of Internal Medicine I, Division of Infectious Diseases and Tropical Medicine, Medical University of Vienna, Vienna, Austria.

Department of Pharmacognosy, University of Vienna, Vienna, Austria.

出版信息

Sci Rep. 2020 Feb 4;10(1):1788. doi: 10.1038/s41598-020-58391-y.

DOI:10.1038/s41598-020-58391-y
PMID:32019947
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7000415/
Abstract

The preferable route for treatment of peritoneal dialysis related peritonitis remains the intraperitoneal administration of antibiotics admixed to peritoneal dialysis fluids. It is important to know whether the administered drug is compatible with the PD fluids and its container. In the present study the compatibility of aztreonam with four commercial PDFs at storing temperatures and duration representative for storing conditions in the clinical settings was investigated. Aztreonam concentrations were determined using high-performance liquid chromatography. The antimicrobial activity of aztreonam was evaluated using an E. coli diffusion disk inhibition assay and P. aeruginosa time-kill curves. In Extraneal evaluated at 6 °C, 25 °C and 37 °C aztreonam was stable over the whole study period of 14 days and 24 hours, respectively. In Physioneal and Nutrineal aztreonam was stable at 6 °C for up to 14 days. Antimicrobial activity was retained in all PD fluids over the whole study period. Aztreonam remained stable and was compatible with the PD fluids, particularly with Extraneal or Nutrineal, and no compensatory dose adjustment is needed when stored for up to 14 days at refrigeration temperature before use.

摘要

治疗腹膜透析相关性腹膜炎的首选方法仍是将抗生素混入腹膜透析液中进行腹腔内给药。了解所给予的药物是否与 PD 液及其容器相容非常重要。在本研究中,考察了在储存温度和持续时间(代表临床环境中的储存条件)下,氨曲南与四种商业 PD 液的相容性。使用高效液相色谱法测定氨曲南的浓度。采用大肠杆菌扩散盘抑制试验和铜绿假单胞菌时间杀伤曲线评估氨曲南的抗菌活性。在 Extraneal 分别于 6°C、25°C 和 37°C 下评估,氨曲南在整个 14 天和 24 小时的研究期间均稳定。在 Physioneal 和 Nutrineal 中,氨曲南在 6°C 下可稳定 14 天。在整个研究期间,所有 PD 液中的抗菌活性均得以保留。氨曲南在 PD 液中稳定,尤其是与 Extraneal 或 Nutrineal 相容,在冷藏温度下储存不超过 14 天,使用前无需进行补偿性剂量调整。